This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Mylan Gmbh. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Akhilesh Dixit: Innovator in Transdermal Therapeutic Systems
Introduction
Akhilesh Dixit is a notable inventor based in Nagpur, India. He has made significant contributions to the field of medical technology, particularly in the development of transdermal therapeutic systems. His innovative work focuses on improving the delivery of medications for neurological disorders.
Latest Patents
Akhilesh Dixit holds a patent for a transdermal therapeutic system designed for the extended dosing of pramipexole. This system allows for the administration of pramipexole or related compounds over an extended period, such as one week. The system features an acrylic-based or silicone-based matrix layer that contains pramipexole at concentrations of at least about 5 wt. % of the matrix. This formulation is resistant to crystallization and discoloration, ensuring the active ingredient remains effective even after long storage periods.
Career Highlights
Akhilesh Dixit is currently associated with Mylan GmbH, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in transdermal systems has positioned him as a valuable asset in the development of advanced therapeutic options.
Collaborations
Akhilesh has collaborated with notable colleagues, including Abhijit Mukund Deshmukh and Prasanna Kumar. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.
Conclusion
Akhilesh Dixit is a pioneering inventor whose work in transdermal therapeutic systems has the potential to transform the treatment of neurological disorders. His innovative approach and dedication to improving medication delivery systems highlight his significant impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
